News | August 02, 2022
Statement from Krsnaa Diagnostics on IT survey
The news report stating Krsnaa Diagnostics has accepted Rs 100 crores of undisclosed income is incorrect and baseless.
The news report stating Krsnaa Diagnostics has accepted Rs 100 crores of undisclosed income is incorrect and baseless.
With this acquisition, UBC provides the most comprehensive REMS services and innovative risk mitigation solutions for the biopharmaceutical industry
The two generic drugs have been launched under the brand names Jankey & Sitenali.
Steps afoot to make RRIH & RRIUM as a Centres of Excellence for Allergic Disorder and for Regimental Therapy respectively
The audit is part of the agency's inspection for three product applications filed and slated to be manufactured at this site.
Driven by a strong commitment to better serve its global customers in medical and consumer products, this investment represents the largest capacity expansion in Cariflex’s existing accomplishments
The Velcade Brand and generic had U.S. sales of approximately $1.2 billion MAT for the most recent twelve months ending in May 2022
Biopharma and CROs to benefit from simplified access to global research sites
The financial assistance by the centre is subject to a maximum limit of Rs.1000 crore per park
Tealium for Pharma utilizes deep integration technology and partnerships to deliver an enhanced customer journey in one of healthcare's most vital sectors
Subscribe To Our Newsletter & Stay Updated
